Literature DB >> 16164008

Biology and epidemiology of Toxoplasma gondii in man and animals.

Dolores E Hill1, Sreekumar Chirukandoth, J P Dubey.   

Abstract

Toxoplasma gondii is a coccidian parasite which utilizes felids as definitive hosts, and which has an unusually wide intermediate host range. The parasite was initially described by Nicolle and Manceaux in 1908 from the rodent, Ctenodactylus gundi. Infection with T. gondii is one of the most common parasitic infections of man and other warm-blooded animals. It has been found worldwide from Alaska to Australia. Nearly one-third of humanity has been exposed to this parasite; serologic surveys indicate that T. gondii infections are common in wild carnivores, including pigs, bears, felids, fox, raccoons, and skunks. Clinical and subclinical toxoplasmosis has been reported from wild cervids, ungulates, marsupials, monkeys, and marine mammals. Southern sea otter populations have been severely impacted by Toxoplasma infections.

Entities:  

Mesh:

Year:  2005        PMID: 16164008     DOI: 10.1079/ahr2005100

Source DB:  PubMed          Journal:  Anim Health Res Rev        ISSN: 1466-2523            Impact factor:   2.615


  147 in total

1.  A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner.

Authors:  Crystal M Tobin; Laura J Knoll
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

2.  Purification, crystallization and preliminary X-ray diffraction analysis of inner membrane complex (IMC) subcompartment protein 1 (ISP1) from Toxoplasma gondii.

Authors:  Michelle L Tonkin; Shannon Brown; Josh R Beck; Peter J Bradley; Martin J Boulanger
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-06-28

3.  Activity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds.

Authors:  Danièle Maubon; Alexandre Bougdour; Yung-Sing Wong; Marie-Pierre Brenier-Pinchart; Aurélie Curt; Mohamed-Ali Hakimi; Hervé Pelloux
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

4.  Coordinate control of host centrosome position, organelle distribution, and migratory response by Toxoplasma gondii via host mTORC2.

Authors:  Yubao Wang; Louis M Weiss; Amos Orlofsky
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

5.  Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors.

Authors:  Baidong Hou; Alicia Benson; Lili Kuzmich; Anthony L DeFranco; Felix Yarovinsky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

6.  Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells.

Authors:  Luke A Gilbert; Sandeep Ravindran; Jay M Turetzky; John C Boothroyd; Peter J Bradley
Journal:  Eukaryot Cell       Date:  2006-11-03

7.  MARveling at parasite invasion.

Authors:  Kristin M Hager; Vern B Carruthers
Journal:  Trends Parasitol       Date:  2008-01-18

8.  Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt.

Authors:  Hany M Elsheikha; Manar S Azab; Nashwa K Abousamra; Mohammad H Rahbar; Doaa M Elghannam; Douaa Raafat
Journal:  Parasitol Res       Date:  2009-02-06       Impact factor: 2.289

Review 9.  Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: focus on Toxoplasma gondii.

Authors:  C E Egan; W Sukhumavasi; B A Butcher; E Y Denkers
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

10.  Development of a Novel Protocol Based on Blood Clot to Improve the Sensitivity of qPCR Detection of Toxoplasma gondii in Peripheral Blood Specimens.

Authors:  Renzo Gutierrez-Loli; Cusi Ferradas; Andrea Diestra; Aliki Traianou; Natalie Bowman; Jeroen Bok; Melissa Reimer-McAtee; Cesar Ramal; Eduardo Ticona; Hannah Steinberg; Holger Mayta; Maritza Calderon; Jaeson S Calla-Choque; Charles Sterling; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.